Translate
Samsung Biologics Co Ltd
About
Samsung Biologics Co Ltd (KO:207940) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 6 2026
Samsung Biologics leads climate transparency with independent validation of Product Carbon Footprint system
Feb 3 2026
CEPI and Samsung Biologics collaborate to strengthen outbreak-ready vaccine production and global access
Jan 28 2026
Samsung Biologics receives EcoVadis Platinum, the highest sustainability rating
Jan 21 2026
Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
Dec 21 2025
Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK
Financials
Revenue
₩4.55 T
Market Cap
₩71.98 T